Shareholding Structure
Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure
Published at 15 April 2026 at 15:35Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 31/03/2026 according to Article 30 of the Listing Rules
The Disclosure Form in Arabic & English (3,235 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 31/03/2026 according to Article 30 of the Listing Rules
The Disclosure Form in Arabic & English (3,235 KB)